NASDAQ:NEO

Neogenomics Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy NEO

*Your capital is at risk

$10.14

+0.0200 (+0.198%)

At Close: Jun 03, 2026

NeoGenomics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 80.90. In total, the insiders bought 3.33M and sold 200.2K NEO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	80.90
● Buy	3.33M shares
● Sell	200.2K shares
75% Buy Activity Strong Negative Correlation
Buy Signal Medium Confidence Mar 02, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 80.9. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 21, 2026 Buy	Restricted Stock Unit M-Exempt	Aunan Greg D Chief Accounting Officer	Officer	6 323 Value: $64.1K
Jan 20, 2026 Sell	Common Stock S-Sale	Stone Warren Pres & Chief Operating Officer	C-Suite Officer	22 128 Value: $276.7K
Jan 13, 2026 Sell	Common Stock F-InKind	Olivo Alicia C EVP, GC & Business Development	Officer	15 145 Value: $0
Jan 13, 2026 Buy	Common Stock M-Exempt	Olivo Alicia C EVP, GC & Business Development	Officer	59 382 Value: $767.8K
Jan 13, 2026 Sell	Common Stock F-InKind	Stone Warren Pres & Chief Operating Officer	C-Suite Officer	15 127 Value: $0
Jan 13, 2026 Buy	Common Stock M-Exempt	Stone Warren Pres & Chief Operating Officer	C-Suite Officer	59 382 Value: $767.8K
Jan 01, 2026 Buy	Restricted Stock Unit A-Award	Kenny John P. Director	Director	5 893 Value: $59.8K
Jan 01, 2026 Buy	Stock Option (Right to Buy) A-Award	Kenny John P. Director	Director	4 171 Value: $49.1K
Jan 01, 2026 Buy	Common Stock J-Other	Kenny John P.	Director	0 Value: $0
Dec 07, 2025 Sell	Common Stock F-InKind	Sherman Jeffrey Scott Chief Financial Officer	C-Suite Officer	11 938 Value: $0
Dec 01, 2025 Sell	Common Stock F-InKind	Stone Warren Pres & Chief Operating Officer	C-Suite Officer	8 776 Value: $0
Nov 25, 2025 Sell	Common Stock S-Sale	Olivo Alicia C EVP, GC & Business Development	Officer	20 916 Value: $251.0K
Nov 25, 2025 Buy	Common Stock M-Exempt	Olivo Alicia C EVP, GC & Business Development	Officer	8 977 Value: $90.2K
Nov 25, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Olivo Alicia C EVP, GC & Business Development	Officer	8 977 Value: $90.2K
Sep 01, 2025 Sell	Common Stock F-InKind	Olivo Alicia C EVP, GC & Business Development	Officer	1 666 Value: $0
Sep 01, 2025 Sell	Common Stock F-InKind	Olivo Alicia C EVP, GC & Business Development	Officer	1 666 Value: $0
Aug 06, 2025 Buy	Common Stock P-Purchase	Sherman Jeffrey Scott Chief Financial Officer	C-Suite Officer	20 000 Value: $112.3K
Aug 06, 2025 Buy	Common Stock P-Purchase	Zook Anthony P. Chief Executive Officer	CEO / President	17 900 Value: $100.0K
Aug 06, 2025 Buy	Common Stock P-Purchase	Zook Anthony P. Chief Executive Officer	CEO / President	17 900 Value: $100.0K
Aug 06, 2025 Buy	Common Stock P-Purchase	Sherman Jeffrey Scott Chief Financial Officer	C-Suite Officer	20 000 Value: $112.3K
Aug 01, 2025 Sell	Common Stock F-InKind	Olivo Alicia C EVP, GC & Business Development	Officer	14 Value: $0
Aug 01, 2025 Sell	Common Stock F-InKind	Olivo Alicia C EVP, GC & Business Development	Officer	14 Value: $0
Jun 19, 2025 Buy	Restricted Stock Unit A-Award	Green Marjorie C Director	Director	22 964 Value: $232.9K
Jun 19, 2025 Buy	Stock Option (Right to Buy) A-Award	Green Marjorie C Director	Director	16 019 Value: $111.3K
Jun 19, 2025 Buy	Common Stock J-Other	Green Marjorie C	Director	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NEOGENOMICS

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fl...

Read Full Profile Here